Chembond Chemicals Limited (NSE:CHEMBONDCH)
India · Delayed Price · Currency is INR 176.78
-6.56 (-3.58%)
At close: Jun 2, 2026
Chembond Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 3,262 | 2,923 | 2,832 | 4,404 | 3,490 |
Other Revenue | 0 | - | - | - | 0 |
| 3,262 | 2,923 | 2,832 | 4,404 | 3,490 | |
Revenue Growth (YoY) | 11.59% | 3.19% | -35.69% | 26.21% | 27.16% |
Cost of Revenue | 1,618 | 1,458 | 1,386 | 2,579 | 2,061 |
Gross Profit | 1,643 | 1,465 | 1,446 | 1,825 | 1,429 |
Selling, General & Admin | 621.13 | 543.06 | 493.79 | 763.23 | 675.55 |
Other Operating Expenses | 548.8 | 491.05 | 522.88 | 689.17 | 558.61 |
Operating Expenses | 1,223 | 1,088 | 1,049 | 1,498 | 1,280 |
Operating Income | 419.85 | 376.34 | 397.12 | 327.01 | 149.32 |
Interest Expense | -6.83 | -0.82 | -0.88 | -5.27 | -3.01 |
Interest & Investment Income | - | 16.31 | 11.2 | 13.01 | 10.9 |
Earnings From Equity Investments | - | 0.05 | 0.05 | -0.11 | - |
Currency Exchange Gain (Loss) | - | -4.07 | -2.79 | -10.71 | -10.13 |
Other Non Operating Income (Expenses) | 39.57 | 8.57 | -0.55 | 0.84 | 2.19 |
EBT Excluding Unusual Items | 452.59 | 396.39 | 404.16 | 324.76 | 149.27 |
Gain (Loss) on Sale of Investments | - | 25.35 | 20.4 | 21.27 | 46.34 |
Gain (Loss) on Sale of Assets | - | - | -0.02 | -0.07 | -0.17 |
Other Unusual Items | - | - | - | -6.6 | - |
Pretax Income | 452.59 | 421.74 | 424.53 | 339.36 | 205.38 |
Income Tax Expense | 104.79 | 112.55 | 124.3 | 87.74 | 65.52 |
Earnings From Continuing Operations | 347.8 | 309.19 | 300.23 | 251.62 | 139.86 |
Minority Interest in Earnings | 1.81 | 1.23 | 0.89 | -0.67 | -0.65 |
Net Income | 349.61 | 310.42 | 301.12 | 250.96 | 139.21 |
Net Income to Common | 349.61 | 310.42 | 301.12 | 250.96 | 139.21 |
Net Income Growth | 12.62% | 3.09% | 19.99% | 80.27% | -31.57% |
Shares Outstanding (Basic) | 27 | 27 | 27 | 13 | 13 |
Shares Outstanding (Diluted) | 27 | 27 | 27 | 13 | 13 |
Shares Change (YoY) | -0.01% | - | 100.00% | - | - |
EPS (Basic) | 13.00 | 11.54 | 11.20 | 18.66 | 10.35 |
EPS (Diluted) | 13.00 | 11.54 | 11.20 | 18.66 | 10.35 |
EPS Growth | 12.65% | 3.08% | -40.00% | 80.29% | -31.58% |
Free Cash Flow | 13.77 | 51.5 | -754.4 | -136.95 | -147.48 |
Free Cash Flow Per Share | 0.51 | 1.92 | -28.05 | -10.18 | -10.97 |
Dividend Per Share | 1.250 | 0.750 | 3.500 | 3.000 | 5.000 |
Dividend Growth | 66.67% | -78.57% | 16.67% | -40.00% | 122.22% |
Gross Margin | 50.39% | 50.12% | 51.05% | 41.44% | 40.94% |
Operating Margin | 12.87% | 12.88% | 14.02% | 7.42% | 4.28% |
Profit Margin | 10.72% | 10.62% | 10.63% | 5.70% | 3.99% |
Free Cash Flow Margin | 0.42% | 1.76% | -26.63% | -3.11% | -4.23% |
EBITDA | 473.39 | 424.2 | 422.66 | 371.21 | 192.65 |
EBITDA Margin | 14.51% | 14.51% | 14.92% | 8.43% | 5.52% |
D&A For EBITDA | 53.54 | 47.85 | 25.53 | 44.19 | 43.34 |
EBIT | 419.85 | 376.34 | 397.12 | 327.01 | 149.32 |
EBIT Margin | 12.87% | 12.88% | 14.02% | 7.42% | 4.28% |
Effective Tax Rate | 23.15% | 26.69% | 29.28% | 25.86% | 31.90% |
Revenue as Reported | 3,301 | 2,981 | 2,869 | 4,451 | 3,576 |
Advertising Expenses | - | 17.19 | 14.62 | 49.48 | 39.06 |